Villeneuve d'Ascq, France

Hubert Hondermarck

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Biomerieux, Inc., Université Des Sciences Et Technologies De Lille, University Des Sciences Et Technologies De Lille. Active years: 2009-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hubert Hondermarck. Retrieved from https://idiyas.com/inventor/hubert-hondermarck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0


Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hubert Hondermarck in Cancer Diagnostics and Therapeutics

Introduction

Hubert Hondermarck is a notable inventor based in Villeneuve d'Ascq, France, whose work has significantly impacted the fields of cancer diagnostics and therapeutics. With a total of three patents under his name, Hondermarck has focused on pioneering methods that advance our understanding and treatment of various cancers, including breast, thyroid, and lung cancer.

Latest Patents

Hondermarck's latest inventions include groundbreaking methods for the in vitro diagnosis of cancer, specifically targeting the presence of ProNGF in biological samples. One of his patents outlines a method for determining ProNGF levels, which can facilitate early diagnosis, screening, and therapeutic follow-up for patients suspected of suffering from breast, thyroid, or lung cancer. Furthermore, he has developed a therapeutic application that involves the use of a ProNGF inhibitor aimed at preparing drugs that can block cell invasion and remote dissemination in cancer patients. These innovations are instrumental in both the diagnosis and treatment of cancer, addressing significant needs in the medical community.

Career Highlights

Hondermarck's career includes valuable roles in organizations that have bolstered his research and innovation efforts. He has contributed his expertise at Biomerieux, Inc. and the University of Science and Technology of Lille. His experience in these institutions has undoubtedly aided in the development of his patented methodologies.

Collaborations

Throughout his career, Hondermarck has collaborated with notable coworkers, including Genevieve Choquet-Kastylevsky and Yohan Demont. These partnerships have further enriched his research outputs and have fostered a collaborative environment conducive to innovation in the fight against cancer.

Conclusion

Hubert Hondermarck's contributions to the field of cancer diagnostics and therapeutics exemplify the vital role of innovation in healthcare. His patented methods not only enhance diagnostic capabilities but also pave the way for new therapeutic approaches, potentially improving outcomes for countless patients. As research in this domain continues to evolve, inventions like Hondermarck's will remain at the forefront of cancer treatment and diagnosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…